CTLA4Ig alone or in combination with low-dose cyclosporine fails to reverse acute rejection of renal allograft in the rat.
Perico
N
N
Mario Negri Institute for Pharmacological Research, Section of Immunohematology, Ospedali Riuniti di Bergamo, Italy.
Amuchastegui
S
S
Bontempelli
M
M
Remuzzi
G
G
D000069594:Abatacept; D000208:Acute Disease; D000818:Animals; D000938:Antigen-Presenting Cells / Q000276:immunology; D015703:Antigens, CD; D000943:Antigens, Differentiation / Q000008:administration & dosage*; D018106:CD28 Antigens / Q000276:immunology; D060908:CTLA-4 Antigen; D016572:Cyclosporine / Q000008:administration & dosage*; D006084:Graft Rejection / Q000188:drug therapy*; D018796:Immunoconjugates; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D016030:Kidney Transplantation / Q000276:immunology*; D008297:Male; D051381:Rats; D011914:Rats, Inbred BN; D011917:Rats, Inbred Lew; D011993:Recombinant Fusion Proteins
D015703:Antigens, CD; D000943:Antigens, Differentiation; D018106:CD28 Antigens; D060908:CTLA-4 Antigen; C556708:Ctla4 protein, rat; D018796:Immunoconjugates; D007166:Immunosuppressive Agents; D011993:Recombinant Fusion Proteins; D000069594:Abatacept; D016572:Cyclosporine